Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience.
about
Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes.Targeted Agents for HER2-Positive Breast Cancer: Optimal Use in Older PatientsLapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO).
P2860
Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lapatinib plus Capecitabine fo ...... al Oncology (ASMO) Experience.
@en
Lapatinib plus Capecitabine fo ...... an Society of Medical Oncology
@nl
type
label
Lapatinib plus Capecitabine fo ...... al Oncology (ASMO) Experience.
@en
Lapatinib plus Capecitabine fo ...... an Society of Medical Oncology
@nl
prefLabel
Lapatinib plus Capecitabine fo ...... al Oncology (ASMO) Experience.
@en
Lapatinib plus Capecitabine fo ...... an Society of Medical Oncology
@nl
P2093
P2860
P356
P1433
P1476
Lapatinib plus Capecitabine fo ...... al Oncology (ASMO) Experience.
@en
P2093
Alper Sevinc
Berna Oksuzoglu
Bulent Cetin
Cem Boruban
Faysal Dane
Gulnihal Tufan
Mahmut Gumus
Suleyman Buyukberber
Ugur Coskun
P2860
P356
10.1159/000346829
P577
2013-03-01T00:00:00Z